🚭 Quit Smoking Today! 💪 Transform Your Life and Embrace Freedom | Inspirational Guide

Ready to break free from the chains of smoking and transform your life? This empowering YouTube video is your ultimate guide to … source
Read moreReady to break free from the chains of smoking and transform your life? This empowering YouTube video is your ultimate guide to … source
Read moreWelcome to “Smoke-Free Life,” where we empower individuals on their journey to quit smoking for good! In this channel, we … source
Read moreIf you are struggling with weed addiction or marijuana addiction this AddictionMindset recovery coaching video is for you! source
Read moreWelcome to episode #8 of Ask an Ex. In this interview, the wonderful Robin Redmond from Massachusetts shares her story of how … source
Read moreThanks for watching! Like, comment ,Subscribe, & Share!! FOR ALL & ANY BUSINESS INQURIES EMAIL ME AT: … source
Read moreEditor’s Note This article is brought to you by Cox Business. Ochsner is embracing its role as a Louisiana medical leader by spearheading a long-term effort to improve the state’s lowly health rankings. The main goal of Ochsner’s Healthy State 2030 initiative is to see Louisiana move into the top 40 in the nation in America’s Health Rankings, where it has consistently placed at the very bottom. To achieve this goal, the health system has launched its own efforts and is partnering with business leaders, educational institutions, […]
Read moreAchieve Life Sciences (NASDAQ:ACHV – Get Rating) will be announcing its earnings results after the market closes on Thursday, August 11th. Analysts expect the company to announce earnings of ($0.79) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Achieve Life Sciences (NASDAQ:ACHV – Get Rating) last released its quarterly earnings data on Thursday, May 12th. The biopharmaceutical company reported ($0.80) earnings per share for the quarter, beating the consensus estimate of ($0.82) by $0.02. During […]
Read moreSEATTLE and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. ( ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it has initiated screening of subjects for the ORCA-V1 Phase 2 clinical trial. ORCA-V1 will evaluate the efficacy and safety of 3mg cytisinicline dosed 3 times daily compared to placebo in approximately 150 adult e-cigarette users at 5 clinical trial locations in the United States. Participants will be randomized […]
Read more